# Opioid Deaths Drop 32% as America Turns Corner on Epidemic: What's Working

Listeners, the opioid epidemic in America is showing unprecedented signs of progress, with overdose deaths plummeting dramatically in recent years. According to the American Medical Association, opioid-related deaths fell from over 110,000 in 2023 to 75,000 in 2025, driven largely by a crackdown on illicit fentanyl, though nearly 60% still involve multiple substances in an increasingly toxic drug supply.

This decline builds on earlier drops: the Centers for Disease Control and Prevention reports a 27% reduction from 83,140 opioid overdoses in 2023 to 54,743 in 2024, with synthetic opioids like fentanyl—now accounting for 89% of cases—falling 37% from 2023 to 2024 per the Congressional Budget Office. CBS News noted overdose deaths slowing 18% since last year's peak, marking 12 straight months of decline as of late 2024. These shifts mark a turning point after more than a decade of escalation, where deaths quadrupled since 1999 and became the leading cause for those under 50.

Yet challenges persist amid this evolution into a polysubstance crisis. The AMA's Substance Use and Pain Care Task Force highlights gaps in pain care, with nonopioid options still inadequate despite opioid prescriptions halving from 260 million in 2012 to 126 million in 2024. Buprenorphine prescriptions for opioid use disorder surged from 1.4 million to 15.4 million over the same period, but stigma, regulations, and insurance barriers limit access. The Congressional Budget Office outlines federal strategies like enhancing prescription drug monitoring programs, expanding Medicaid and telehealth for treatment, and boosting naloxone distribution, all proven to cut misuse, hospitalizations, and mortality.

Public sentiment reflects urgency and nuance. A Weill Cornell Medicine survey in JAMA Network Open found 88% of Americans across political lines view opioid overdoses as a very serious crisis, though conservatives emphasize personal responsibility while liberals point to pharmaceutical companies—potentially fueling lawsuits and settlement-funded programs. North Carolina's Department of Health and Human Services, in a March 2026 meeting, focused on high-risk justice-involved populations, where overdoses spike post-release; the state expects $1.6 billion from national opioid settlements to fund diversion, treatment in corrections, and reentry support.

Experts like AMA President Bobby Mukkamala stress decisive action: eliminate prior authorizations for treatments like bu

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

This content was created in partnership and with the help of Artificial Intelligence AI

This episode includes AI-generated content.